Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer

Japanese Journal of Clinical Oncology

Volumn 40, Issue 4, 2010, Pages 336-342

  Lu, Hai Bo ^a   Zhou, Jian Hua ^a   Ma, Yu Yan ^b   Lu, Hai Ling ^a   Tang, Ya Li ^b   Zhang, Qing Yuan ^a   Zhao, Chang Hong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Institute of Heilongjiang Province   (China)

Author keywords

Biomarker; CA19 9; CEA; Gastric cancer; SELDI TOF MS

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PLASMA PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; DECISION TREE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; AGED; ALGORITHM; BLOOD; CLASSIFICATION; CLUSTER ANALYSIS; MASS SPECTROMETRY; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

ADULT; AGED; ALGORITHMS; BLOOD PROTEINS; CLUSTER ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951241041     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp175     Document Type: Article

References (28)

1. Bruckner HW, Morris JC, Mansfield P. Neoplasms of the stomach. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E, III, et al. editors. Cancer Medicine, 5th ed. Ontario, British Columbia: Decker Inc., 2000
2. Ling XL, Fang DC, Wang RQ, Yang SM, Fang L. Mitochondrial microsatellite instability in gastric cancer and its procancerous lesions. World J Gastroenterol 2004;10:800-3.
3. Sugano K. Gastric cancer: pathogenesis, screening, and treatment. Gastrointest Endosc Clin N Am 2008;18:513-22. ix.
4. di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis 2008;40:523-30.
5. Opocher E, Santambrogio R, Bianchi P, Cioffi U, De Simone M, Vellini S, et al. Isolated splenic metastasis from gastric carcinoma: value of CEA and CA 19-9 in early diagnosis: report of two cases. Am J Clin Oncol 2000;23:579-80.
6. Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 2006;27:251-9.
7. Hutchen TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-80.
8. Wadsworth JT, Somers KD, Cazares LH, Malik G, Adam BL, Stack BC, Jr, et al. Serum protein profiles to identify head and neck cancer. Clin Cancer Res 2004;10:1625-32.
9. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002;62:1868-75.
10. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, et al. Normal benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2002;8:2541-52.
11. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, et al. Serum diagnosis of pancreatic adenocarcinoma using surface enhanced laser desorption/ionization mass spectrometry. Clin. Cancer Res 2004;10:860-8.
12. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
13. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
14. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-502.
15. de Noo ME, Tollenaar RA, Deelder AM, Bouwman LH. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears. World J Gastroenterol 2006;12:6594-601.
16. Ward DG, Nyangoma S, Joy H, Hamilton E, Wei W, Tselepis C, et al. Proteomic profiling of urine for the detection of colon cancer. Proteome Sci 2008;6:19.
17. Sobin LH, Wittekind CH. International Union Against Cancer. TNM classification of malignant tumors. 5th edition. New York: John Wiley & Sons, Inc 1997.
18. Ding SY, Qian DM, Yan ZY, Song XX, Mou WF, Wang B. Identification of protein differently expressed between hepatoma cell line and Hepatitis B Virus-transfected hepatoma cell line. World Chin J Gastroenterol 2005;13:1684-7.
19. Wu C, Luo Z, Chen X, Wu C, Yao D, Zhao P, et al. Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol Rep 2009;21:1429-37.
20. Deininger SO, Ebert MP, Fü tterer A, Gerhard M, Röcken C. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res 2008;7:5230-6.
21. Zhiqiang Z, Maoyu L, Guiying Z, Fang P, Huixing Y, Zhiqiang X, et al. Identification of human gastric carcinoma biomarkers by differential protein expression analysis using (18)O labeling and NanoLC-MS/MS coupled with laser capture microdissection. Med Oncol 2009; 28 March 2009 [Epub ahead of print].
22. Khoder G, Yamaoka Y, Fauchère JL, Burucoa C, Atanassov C. Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:1193-9.
23. Wu ZZ, Wang JG, Zhang XL. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol 2009;15:865-70.
24. Li W, Li JF, Qu Y, Chen XH, Qin JM, Gu QL, et al. Comparative proteomics analysis of human gastric cancer. World J Gastroenterol 2008;14:5657-64.
25. Qian HG, Shen J, Ma H, Ma HC, Su YH, Hao CY, et al. Preliminary study on proteomics of gastric carcinoma and its clinical significance. World J Gastroenterol 2005;11:6249-53.
26. Liang Y, Fang M, Li J, Liu CB, Rudd JA, Kung HF, et al. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp Mol Pathol 2006;81:176-80.
27. Su Y, Shen J, Qian H, Ma H, Ji J, Ma H, et al. Diagnosis of gastric cancer using decision tree classification of mass spectral data. Cancer Sci 2007;98:37-43.
28. Lim JY, Cho JY, Paik YH, Chang YS, Kim HG. Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Biol Markers 2007;22:281-6.